Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I Disorder

NCT00094549 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Disorder

Interventions

DRUG: olanzapine
DRUG: divalproex sodium
DRUG: placebo

Sponsor

Eli Lilly and Company